Comparison of BiomeOne and PD-L1 expression tests as a predictor for response to immune checkpoint inhibitors (ICI) in patients with non-small cell lung cancer (NSCLC)

被引：1
|
作者：
Robinson, I. [1 ]
Hochmair, M. J. [1 ]
Ay, L. [1 ]
Absenger, G. [2 ]
Jansen, C. [3 ]
Pacifico, C. [3 ]
Sladek, B. [3 ]
Knabl, A. [3 ]
Gasche, N. [3 ]
Valipour, A. [1 ]
机构：
[1] Karl Landsteiner Inst Lung Res & Pulm Oncol, Vienna, Austria
[2] Graz Univ Klin Innere Med, LKH Univ Klinikum, Graz, Austria
[3] Biome Diagnost GmbH, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 08期
关键词：
D O I：
10.1016/j.annonc.2022.09.056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
55P
引用
收藏
页码：S1400 / S1400
页数：1
相关论文
共 50 条
  • [1] VALIDATION OF PD-L1 DYNAMIC EXPRESSION ON EXTRACELLULAR VESICLES AS A PREDICTOR OF RESPONSE TO IMMUNE-CHECKPOINT INHIBITORS AND SURVIVAL IN NON-SMALL CELL LUNG CANCER PATIENTS
    de Miguel Perez, Diego
    Barron, Feliciano
    Russo, Alessandro
    Lara-Mejia, Luis
    Gunasekaran, Muthukumar
    Cardona, Andres
    Peterson, Christine
    Colen, Rivka
    Naing, Aung
    Mack, Philip
    Hirsch, Fred
    Adamo, Vincenzo
    Arrieta, Oscar
    Rolfo, Christian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A25 - A26
  • [2] Investigation of response factors for monotherapy with immune checkpoint inhibitors in non-small cell lung cancer patients with PD-L1 expression <50%
    Takahara, Yutaka
    Abe, Ryudai
    Sumito, Nagae
    Tanaka, Takuya
    Ishige, Yoko
    Shionoya, Ikuyo
    Yamamura, Kouichi
    Nishiki, Kazuaki
    Nojiri, Masafumi
    Kato, Ryo
    Shinomiya, Shohei
    Oikawa, Taku
    THORACIC CANCER, 2023, 14 (27) : 2754 - 2760
  • [3] Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC)
    Papavassiliou, Kostas A. A.
    Marinos, Georgios
    Papavassiliou, Athanasios G. G.
    CELLS, 2023, 12 (06)
  • [4] Cost Effectiveness of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Relative to PD-L1 Expression
    Aguiar, Pedro, Jr.
    De Mello, Ramon
    Tadokoro, Hakaru
    Santoro, Ilka
    Babiker, Hani
    Avancha, Kiran
    Gutierres, Barbara
    Barreto, Carmelia
    Lopes, Gilberto
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S169 - S170
  • [5] Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer
    Shien, Kazuhiko
    Papadimitrakopoulou, Vassiliki A.
    Wistuba, Ignacio I.
    LUNG CANCER, 2016, 99 : 79 - 87
  • [6] Biomarkers of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Beyond PD-L1
    Cabezon-Gutierrez, Luis
    Custodio-Cabello, Sara
    Palka-Kotlowska, Magda
    Alonso-Viteri, Soledad
    Khosravi-Shahi, Parham
    CLINICAL LUNG CANCER, 2021, 22 (05) : 381 - 389
  • [7] PD-L1 and granzyme A mRNA expression associated with prognosis and response to immune checkpoint inhibitors in non-small cell lung cancer
    Song, Zhengbo
    Lu, Chenyu
    Wang, Hongxiang
    Xu, Chunwei
    Zhang, Baifeng
    Wang, Wenxian
    Chen, Juxiang
    Zheng, Zongli
    CANCER RESEARCH, 2020, 80 (16)
  • [8] Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Hara, Naofumi
    Ichihara, Eiki
    Harada, Daijiro
    Inoue, Koji
    Fujiwara, Keiichi
    Hosokawa, Shinobu
    Kishino, Daizo
    Haruyuki, Kawai
    Ochi, Nobuaki
    Oda, Naohiro
    Hotta, Katsuyuki
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (12) : 3749 - 3755
  • [9] Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Naofumi Hara
    Eiki Ichihara
    Daijiro Harada
    Koji Inoue
    Keiichi Fujiwara
    Shinobu Hosokawa
    Daizo Kishino
    Kawai Haruyuki
    Nobuaki Ochi
    Naohiro Oda
    Katsuyuki Hotta
    Yoshinobu Maeda
    Katsuyuki Kiura
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 3749 - 3755
  • [10] Exosomal PD-L1 expression as non-invasive biomarker for immune checkpoint inhibitors in non-small cell lung cancer
    Gunasekaran, Muthukumar
    Russo, Alessandro
    Cardona, Andres F.
    Perez, Diego de Miguel
    Lapidus, Rena
    Cooper, Brandon
    Kaushal, Sunjay
    Adamo, Vincenzo
    Rolfo, Christian
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
12345